229 related articles for article (PubMed ID: 26209860)
1. Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects.
Metzger CD; Wiegers M; Walter M; Abler B; Graf H
Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209860
[TBL] [Abstract][Full Text] [Related]
2. Erotic stimulus processing under amisulpride and reboxetine: a placebo-controlled fMRI study in healthy subjects.
Graf H; Wiegers M; Metzger CD; Walter M; Grön G; Abler B
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25612894
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic modulation of neural erotic stimulus perception.
Graf H; Wiegers M; Metzger CD; Walter M; Grön G; Abler B
Eur Neuropsychopharmacol; 2017 Sep; 27(9):845-853. PubMed ID: 28683981
[TBL] [Abstract][Full Text] [Related]
4. Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging.
Grimm O; Kopfer V; Küpper-Tetzel L; Deppert V; Kuhn M; de Greck M; Reif A
Hum Brain Mapp; 2020 May; 41(7):1806-1818. PubMed ID: 31880365
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers.
McCabe C; Mishor Z
Neuroimage; 2011 Aug; 57(4):1317-23. PubMed ID: 21640839
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.
Samuels ER; Hou RH; Langley RW; Szabadi E; Bradshaw CM
Psychopharmacology (Berl); 2006 Sep; 187(4):498-510. PubMed ID: 16802163
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic Enhancement of Striatal Response to Reward in Major Depression.
Admon R; Kaiser RH; Dillon DG; Beltzer M; Goer F; Olson DP; Vitaliano G; Pizzagalli DA
Am J Psychiatry; 2017 Apr; 174(4):378-386. PubMed ID: 27771973
[TBL] [Abstract][Full Text] [Related]
8. Dopamine Modulates the Functional Organization of the Orbitofrontal Cortex.
Kahnt T; Tobler PN
J Neurosci; 2017 Feb; 37(6):1493-1504. PubMed ID: 28069917
[TBL] [Abstract][Full Text] [Related]
9. Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing.
Graf H; Wiegers M; Metzger CD; Walter M; Abler B
Front Psychiatry; 2018; 9():346. PubMed ID: 30108528
[TBL] [Abstract][Full Text] [Related]
10. Effects of amisulpride on human resting cerebral perfusion.
Viviani R; Graf H; Wiegers M; Abler B
Psychopharmacology (Berl); 2013 Sep; 229(1):95-103. PubMed ID: 23584671
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
[TBL] [Abstract][Full Text] [Related]
12. The effects of reboxetine, a noradrenaline reuptake inhibitor, on the plasma noradrenaline response to a cold pressor test in healthy volunteers.
Kelly CB; McAree S; Cooper SJ; Stevenson M
J Psychopharmacol; 2002 Dec; 16(4):333-6. PubMed ID: 12503832
[TBL] [Abstract][Full Text] [Related]
13. Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.
Klumpers LE; Cole DM; Khalili-Mahani N; Soeter RP; Te Beek ET; Rombouts SA; van Gerven JM
Neuroimage; 2012 Nov; 63(3):1701-11. PubMed ID: 22885247
[TBL] [Abstract][Full Text] [Related]
14. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
Linnér L; Endersz H; Ohman D; Bengtsson F; Schalling M; Svensson TH
J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
[TBL] [Abstract][Full Text] [Related]
15. No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.
Grimm O; Nägele M; Küpper-Tetzel L; de Greck M; Plichta M; Reif A
Psychopharmacology (Berl); 2021 May; 238(5):1333-1342. PubMed ID: 33140215
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.
Brühl AB; Kaffenberger T; Herwig U
Neuropsychopharmacology; 2010 Jan; 35(2):521-33. PubMed ID: 19847160
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study.
Takahashi H; Yahata N; Koeda M; Takano A; Asai K; Suhara T; Okubo Y
Neuroimage; 2005 Oct; 27(4):991-1001. PubMed ID: 15978846
[TBL] [Abstract][Full Text] [Related]
18. Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.
Kuo HI; Paulus W; Batsikadze G; Jamil A; Kuo MF; Nitsche MA
Int J Neuropsychopharmacol; 2017 Aug; 20(8):634-643. PubMed ID: 28430976
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Modulation of Noradrenergic Arousal Circuitry Disrupts Functional Connectivity of the Locus Ceruleus in Humans.
Song AH; Kucyi A; Napadow V; Brown EN; Loggia ML; Akeju O
J Neurosci; 2017 Jul; 37(29):6938-6945. PubMed ID: 28626012
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic receptor blockade changes a functional connectivity network centred on the amygdala.
Haaker J; Menz MM; Fadai T; Eippert F; Büchel C
Hum Brain Mapp; 2016 Nov; 37(11):4148-4157. PubMed ID: 27412789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
